Launch of First Pancreatic Cancer Clinical Trial with CEB-01 in Spain

We are pleased to announce our first clinical trial in pancreatic cancer, using our innovative product CEB-01. This study is being conducted at four leading hospitals in Spain: Virgen del Rocío University Hospital (Seville), Valencia University Clinical Hospital, San Carlos Clinical Hospital (Madrid), and the Clínic of Barcelona. We are committed to improving local cancer control during surgery and offering new hope to patients. Discover more details in our attached press release. 2025-03-31 Press release Pancreas – Download

The release as fetched from its publisher. cebiotex.com ↗